Apollo Therapeutics Signs Exclusive Ex-China License From Sunshine Lake Pharma for Clinical-Stage FGF21 / GLP-1 Dual Receptor Agonist, a Therapeutic With Major Commercial Potential in Multiple Indications Read more
Ontada Collaborates with Datavant to Enable Faster Access to Market-Leading Oncology Insights Read more
Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia Read more
FDA Removes Clinical Hold on Novavax’s COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial Read more
Celebrating More than a Decade of Excellence at the World ADC Awards – Winners Announcement Read more
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders Read more
Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema Read more
Leads Biolabs Secures Orphan Drug Designation from US FDA for LBL-034, a Novel Anti-GPRC5D/CD3 Bispecific Antibody Targeting Multiple Myeloma Read more
Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis Read more